DS
INM icon

DRW Securities’s InMed Pharmaceuticals INM Stock Holding History

DRW Securities’s Portfolio INM Stock Details INM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,865
Closed -$78.5K – 1444
2025
Q3 		$78.5K Buy
+35,865
New +$86.5K ﹤0.01% 1203

Other funds holding INM

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

DRW Securities's INM Position: Q4 2025 in Review

DRW Securities sold out of InMed Pharmaceuticals (INM) in Q4 2025, closing a stake of 35,865 shares — an estimated $78.5K sold.

DRW Securities first reported a position in INM in Q3 2025 and held it in 1 quarter. The position peaked at $78.5K in Q3 2025. 7 funds tracked by Wall St. Rank hold INM as of Q4 2025.

  • DRW Securities reported no remaining InMed Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • DRW Securities sold 35,865 InMed Pharmaceuticals shares in Q4 2025, an estimated $78.5K.
  • DRW Securities first reported a position in InMed Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • DRW Securities's InMed Pharmaceuticals position peaked at $78.5K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held InMed Pharmaceuticals as of Q4 2025.

Based on DRW Securities's 13F filing for Q4 2025, filed 12 Feb 2026.